L ung carcinoid tumor is a rare malignant disease made up of neuroendocrine cells. These cells resemble endocrine cells because they both excrete hormone substances and are also like nerve cells due to their release of neurotransmitters. 1 In the lungs, these hormones and substances assist in the regulation of air and blood fl ow that helps in the growth of other types of lung cells.
Neuroendocrine tumors can develop anywhere in the body. These can form in different organs such as the lungs, appendix, small intestine, rectum and pancreas. 2 Carcinoid bronchopulmonary tumors constitute a quarter of all carcinoid tumors and 1-2% of all lung cancers. 2, 3 About 70% of these tumors are found in the main bronchial airways leading to the lungs, while 10-20% are found in the peripheral areas of the lung. 2 The World Health Organization has classifi ed neuroendocrine pulmonary tumors into 4 types: typical carcinoid (grows slowly and rarely spreads beyond the lungs), atypical carcinoid (grows a little faster and may metastasize but is rarer), large cell neuroendocrine carcinoma and small cell lung cancer. 2, 4 Since this disease develops slowly, approximately 25% of patients with carcinoid lung tumors present no symptoms. 5 For some, the physical manifestations depend on the size of tumor, its location and type of hormones produced. The most common symptoms are cough, wheezing, chest discomfort, blood in sputum and diffi culty of breathing.
interventional techniques such as Nd YAG laser treatments, electrocautery, endobronchial brachytherapy, photodynamic therapy and cryotherapy in the management of carcinoid tumors. These procedures, and in particular cryosurgery is less invasive, versatile, fast and has been shown to be very effective.
The aim of this study is to illustrate the effi cacy and safety of cryosurgery in treatment of an isolated carcinoid tumor in the lung through a case report.
Case Report
A case of a Yemeni, 22-year-old male, a non-smoker, with no known underlying conditions, was diagnosed with a lung carcinoid tumor, left upper lobe. Three weeks prior to consultation, he was admitted to a local hospital in his country because of fever, chronic cough and malaise. He was initially diagnosed with Pneumonia and was treated with antibiotics. He seemed to improve clinically but later developed left upper lobe segment collapse as seen on his chest x-ray. He then underwent a Chest CT scan which revealed left upper lobe collapse with total blockage of the left upper lobar bronchus immediately at the hilar level with suspicious bronchial fi lling defect. Suspicious left para hilar fullness was seen refl ecting possible mass lesion or adenopathy. Prevascular mediastinal lymph node was observed and measured at 17x8 mm diameter ( Figure 1) . Fiberoptic bronchoscopy showed a large ball-like soft tissue mass obliterating and almost totally closing the left upper lobe bronchus. A biopsy was performed and specimens were extracted for cytology, fl uid culture and sensitivity, acid fast bacilli and fungal studies. The histopathology report revealed that the cytomorphological features with the immunohistochemical markers supported the diagnosis of bronchial well differentiated neuroendocrine tumor (carcinoid tumor). He decided to seek a second opinion from Bangkok Hospital.
Upon arrival to Thailand, he was asymptomatic with the following vital signs: temperature: 36.3 o C, pulse rate: 73 beats per minute, respiratory rate: 18 cycles beats per minute, Blood pressure: 128/74 mmHg, O2 saturation: 98%. His test results and radiographic images were reviewed and two options were considered. First, since the patient presents as clinically stable with no signs of hypoxia or bleeding, he is eligible to undergo cryosurgery with argon plasma coagulation to stop bleeding; the second option is lobectomy. The family and patient refused lobectomy and chose to fi rst conduct additional investigations through a 18F-FDG PET/CT scan for further evaluation to help provide more specifi c information on the primary site as well as any secondary deposit. The 18F-FDG PET/CT scan revealed hypermetabolic focus at the left lingular segment of the left upper lobe. The atelectasis of the left upper lung shows increased 18F-FDG uptake standardized uptake value (SUV of 1.9 ( Figure 2 ). No other hypermetabolic site is observed. Finally, the patient accepted to undergo cryosurgery with argon plasma coagulation.
Prior to the procedure, his lung function was evaluated and revealed a FEF 25-70% of 75%. Pre-operative protocols were observed and he was prepared for the procedure. Bronchoscopic cryo surgery equipment was put together. The bronchoscope, cryo machine with foot control, suitable size cryoprobes and cooling agent (carbon dioxide) were prepared. Before beginning the procedure, the probe tip was tested directly and made sure that is has no leakage.
Technical procedure
The patient was placed under general anesthesia. Once breathing has been stabilized, a fi beroptic bronchoscope was inserted through the tube into the left main bronchus then through the left upper lobe bronchus where the tumor was thoroughly examined. Once the tumor is located, the fl exible cryo probe is inserted to the working channel and is placed on the surface of the tumor with gentle pressure. The cryo machine is then activated and carbon dioxide is released, controlled through the foot pedal. Once the target tissue was frozen, a short pull to help tear the tissue was done. The freezing and pulling technique was performed 5 times, 20 seconds of freezing each time until the whole tumor was successfully removed. The cryo was maintained until the piece of the tumor was properly thawed in a liquid container for histopathological studies. After the freezing and extraction of tumor, argon plasma coagulation was done to abruptly stop the bleeding. Immediately post procedure, the patient stayed in the recovery room for close monitoring. No post-operative complications were noted. Two days after the cryo surgery, breathing had improved greatly with a lung function test result of FEF 25-70% of 89% (Table 1) . His chest x-ray revealed a partial clear infi ltration of the left lung. Histopathology report revealed atypical carcinoid with necrotic foci. A repeat Chest CT scan after 3 months was recommended to evaluate any regrowth of the tumor.
Discussion
A carcinoid tumor is a rare malignant disease which is frequently managed by surgery especially when it is confi ned only in one area of the lung. The diagnosis of this tumor is based on the patient's signs and symptoms, radiographic imaging such as chest x-ray and CT scan, confi rmed by bronchoscopic procedure and tissue analysis. Imaging of the tumor is very important as this illustrates the location, size, characteristic of the tumor and if there is any nodal involvement. 7, 8 The best and most appropriate management is determined once diagnosis through CT scan and tissue analysis has been established. For this case, in less than 3 weeks since the onset of symptoms, cryosurgery was decided to be the best treatment option for the carcinoid tumor. The process of diagnosis was effi cient and prompt. Once the physicians found the left upper lobe segment collapse in his chest x-ray, this was followed up immediately by chest CT scan and bronchoscopy with biopsy that confi rmed a well differentiated neuroendocrine tumor (carcinoid tumor). No metastases were seen on the radiographic images but the size of the tumor was initially a concern as to whether using cryosurgery would be suffi cient in extracting the whole tumor. As mentioned, surgery was offered but the family and patient refused and opted to undergo the less invasive route which is cryosurgery.
According to what we know so far, there is no consensus in treating lung carcinoid tumor. In the past, therapeutic options were focused on surgical resection of the tumor. As this strategy failed to avoid development of recurrence, different techniques such as endoscopic methods have been introduced.
Several published studies encourage the use of less invasive techniques as this is very effective in extracting tumors which improves clinical symptoms and increases the overall survival rates. [10] [11] [12] [13] [14] [15] [16] [17] [18] In a study by Seon-Heui Lee et al. 19 endoscopic cryotherapy illustrated approximately 80% effi cacy and has greatly improved patient's quality of life. Unlike other endoscopic techniques, cryosurgery is not linked with prolonged complications such as bronchial stenosis, excessive bleeding and avoids collagen damage. 10 The depth of extraction in the bronchial wall is > 3 mm which is enough to treat early stage lung malignancies. 20 It has no risk of electrical accidents, does not require laser training and certifi cation, can be done several times and allows surgical salvage if needed. 9, 21 In a study by Dr. Deygas et al. 9 they illustrated the excellent tolerance to cryotherapy. There were no signs of bleeding, dyspnea, chronic cough, bronchial wall perforation and no severe side effects related to general anesthesia shown by their subjects. As for our experience, argon plasma coagulation was utilized in order to immediately seize the bleeding. Also, no untoward signs and symptoms post procedure were recorded.
In terms of the number cycles and seconds used to freeze the tumor, we were able to completely extract the whole carcinoid tumor with 5 cycles of 20 second freezing time. A number of research studies have been published pertaining to the duration of the application of cryoprobe and how many cycles should be performed in order to maximize satisfactory results. In a research by Dr. Bertoletti et al. 7 2 methods were used in cryotherapy. One is three cycles of freezing for 20 seconds used in St. Etienne, and the other is 30 seconds in Montreal, then thawing was performed at each site. 10 Meanwhile, in a study by Noppen et al. 22 they performed 3x20 second cycles of -80 o C cryotherapy. In a systematic review by Seon-Heui Lee et al. 19 the technique of cryotherapy used by 9 different published studies has a range temperature Saenghirunvattana S, et al.
of -70°C to -160°C and a varying time of 5 seconds to 3 minutes. Clearly, there is no specifi c guideline in using cryotherapy. Time and the number of cycles depend on several factors which includes the type of equipment, size and depth of tumor and of course the operator of the cryoprobes.
Among lung cancers, carcinoid tumors have the highest success rates. Typical carcinoid tumor has a 5-year survival rate of 92-100% while atypical tumor has a 61-88% survival rate. 23 This becomes lower to 4-35% if there are metastases to other organs. 24, 25 Atypical tumors are rarer than typical tumors but grow faster and have a tendency to metastasize. These tumors are more frequent in males and the average age onset of this disease is 46 years old. 26 The effi cacy of radiotherapy and chemotherapy is still under discussion. 27 In a study by Mitry et al. 28 they found that poorly differentiated neuroendocrine tumors respond to the cytotoxic agents cisplatin and etoposide. However the 2-year survival is signifi cantly low at less than 20%.
A lung carcinoid tumor is an infrequent disease which makes it more challenging to treat. Earlier management was focused on surgery and for some, it is still considered as the gold standard in treating carcinoid tumors. Given the lack of consensus in managing this kind of disease, less invasive strategies such as cryosurgery has been introduced by many interventional pulmonologists, as this procedure is safe, effective and has signifi cantly higher tolerance to surgery. Although there were delayed results reported and multiple endoscopies to be performed to extract the whole tumor, 21 this procedure is defi nitely more practical, aggressive yet less invasive and more conservative than surgery. In conclusion, physicians and scientists should be able to objectively compare and research more into considering cryosurgery as a fi rst-line therapy for carcinoid tumors without metastases.
